Watch our Real World Dialogues session with Dr. Leroy Hood here.

hero-line-left hero-line-top

Real-world evidence to inform real-world cancer care

Syapse partners with health systems, life sciences companies, and regulators to create a unified ecosystem and deliver clinical, programmatic, and valuable real-world data insights to advance precision medicine in the field of oncology.

icon-line icon

Get the Right Therapy

Syapse helps health systems leverage real-world treatment trends, clinical characteristics, and outcomes to guide treatment decisions.

For Health Systems
icon-line icon

Get the Therapy Right

Syapse helps life sciences companies by partnering to create high quality, fully integrated clinical genomic datasets that can be used to accelerate approvals.

For Life Sciences
icon-line icon

Get the Evidence Right

Syapse helps regulators through collaboration, to apply our expertise to the shaping of regulatory standards for the creation of real-world evidence.

Learning Health Network

What's new

Syapse Looks to Dive Deeper Into Large Health Systems for Data-Driven Cancer Insights

Fresh off a $68 million funding round, Syapse is moving quickly to expand its network of partnerships with life sciences companies, health systems, molecular laboratories, and regulators. “We’re right in the middle of growth mode right now,” CEO Ken Tarkoff said of the 13-year-old company. The San Francisco-based maker of software to support precision oncology care and drug discovery also raised $30 million in a round that closed in May 2020.



The Innovation Engine That Could: Why It is Important to Carve Out Time to Innovate

Syapse made its presence known in the precision medicine and real-world evidence space over a decade ago. In this time, the use and understa…


Let’s talk

If you’d like to learn more about Syapse, tell us a little about yourself and we will reach out as soon as possible.